Search for notes by fellow students, in your own course and all over the country.

Browse our notes for titles which look like what you need, you can preview any of the notes via a sample of the contents. After you're happy these are the notes you're after simply pop them into your shopping cart.

My Basket

You have nothing in your shopping cart yet.

Title: Atherosclerosis
Description: What is atherosclerosis, its mechanism, its treatment, its furture targeted and possible treatments

Document Preview

Extracts from the notes are below, to see the PDF you'll receive please use the links above


ATHEROSCLEROSIS  
-­‐ progressive  disease  of  ARTERIES,  
accumulation  of  LIPIDS  and  FIBROUS  
TISSUE  in  tunica  intima  of  vessels  
-­‐ primary  cause  of  CORONARY  HEART  
DISEASE  and  STROKE  
-­‐ leads  to  MYOCARDIAL  ISCHAEMIA    
 
1
...
   
-­‐ Foam  cells  accumulate,  apoptosis  explode  
and  leave  lipid  core  
-­‐ Proliferation  &  matrix  formation  by  intimal  
“synthetic”  smooth  muscle  cells  forms  
fibrous  cap  
-­‐ Thrombosis  caused  by  rupture  of  fibrous  
cap  (eg  by  proteolytic  enzymes  released  by  
inflammatory  cells)    

 
2
...
2-­‐0
...
5%  -­‐  2
...
 (no  more  back  to  
liver  to  aid  in  bile  acid  synthesis)  More  
cholesterol  is  needed  for  bile  acid  synthesis  -­‐>  
increases  hepatic  LDL  receptor  expression  -­‐>  
reduce  serum  LDL  
-­‐  ADVERSE  :  GI  intolerance,  intefers  with  other  
drug  actions  eg  binds  other  –ve  charged  drugs,  
impeding  their  adsorption  
 
FIBRIC  ACID  DERIVATIVES  
-­‐ gemfibrozil,  fenofibrate    
-­‐ increases  HDL  &  reduces  LDL  +  VLDL  by  
activating  PPAR-­‐alpha  which  regulates  
expression  of  key  protein  in  HDL  synthesis,  
HDL  mediated  reverse  cholesterol  transport  
and  lipoprotein  lipolysis    
-­‐ ADVERSE  –  GI  upset,  gallstones  
 
NICOTINIC  ACID  
-­‐ niacin  

 

 

-­‐ activate  GPCR  G  protein  -­‐>  inhibits  lipolysis  
-­‐>  reduced  plasma  free  fatty  acids  -­‐
>reduced  hepatic  production  of  VLDL  which  
are  precursors  of  LDL  -­‐>  lower  serum  LDL  
levels  
-­‐ increases  HDL  by  inducing  apo  –  A1  
-­‐ ADVERSE  :  flush,  itch,  headache,  
hyperglycaemia,  decreased  insulin  
sensitivity  
Ezetimibe  
-­‐ Indirect  inhibition  of  NPC1L1  -­‐>  blocks  
intestinal  cholesterol  absorbtion    
-­‐ Loweres  serum  LDL  levels  
-­‐ ADVERSE  :  GI  intolerance,  joint/back  pain  
3
Title: Atherosclerosis
Description: What is atherosclerosis, its mechanism, its treatment, its furture targeted and possible treatments